Johnson Investment Counsel’s Immunomedics Inc IMMU Stock Holding History

Johnson Investment Counsel’s Portfolio IMMU Stock Details IMMU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-3,175	Closed	-$270K	–	617
2020 Q3	$270K	Buy	+3,175	New	+$161K	0.01%	492

Johnson Investment Counsel's IMMU Position: Q4 2020 in Review

Johnson Investment Counsel sold out of Immunomedics Inc (IMMU) in Q4 2020, closing a stake of 3,175 shares — an estimated $270K sold.

Johnson Investment Counsel first reported a position in IMMU in Q3 2020 and held it in 1 quarter. The position peaked at $270K in Q3 2020. 0 funds tracked by Wall St. Rank hold IMMU as of Q4 2020.

Johnson Investment Counsel reported no remaining Immunomedics Inc position as of Q4 2020 after selling out during the quarter.
Johnson Investment Counsel sold 3,175 Immunomedics Inc shares in Q4 2020, an estimated $270K.
Johnson Investment Counsel first reported a position in Immunomedics Inc in Q3 2020 and held it in 1 quarter.
Johnson Investment Counsel's Immunomedics Inc position peaked at $270K in Q3 2020.
0 funds tracked by Wall St. Rank held Immunomedics Inc as of Q4 2020.

Based on Johnson Investment Counsel's 13F filing for Q4 2020, filed 12 Feb 2021.